Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 289,897 | 233,351 | 218,389 | 183,278 | 135,943 |
| Receivables | 20,288 | 24,672 | 16,592 | 12,109 | 17,563 |
| Inventories | 2,291 | 1,404 | 1,052 | 1,209 | 769 |
| TOTAL | $317,993 | $266,150 | $237,737 | $199,799 | $158,801 |
| Non-Current Assets | |||||
| PPE Net | 12,291 | 11,923 | 12,114 | 12,360 | 12,785 |
| Investments And Advances | 23,479 | 17,566 | 11,723 | 11,148 | 11,148 |
| Intangibles | 14,442 | 14,629 | 11,039 | 6,667 | 7,022 |
| Other Non-Current Assets | 22,838 | 23,145 | 23,266 | 38,599 | 39,003 |
| TOTAL | $73,050 | $67,263 | $58,142 | $68,774 | $69,958 |
| Total Assets | $391,043 | $333,413 | $295,879 | $268,573 | $228,759 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 39,181 | 45,389 | 32,584 | 32,981 | 35,347 |
| Other current liabilities | N/A | N/A | 3,000 | 413 | 69 |
| TOTAL | $53,820 | $51,760 | $37,281 | $56,969 | $51,732 |
| Non-Current Liabilities | |||||
| Long Term Debt | 57,599 | 59,814 | 51,393 | 64,157 | 70,866 |
| Deferred Revenues | 7,200 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 52,643 | 40,035 | 45,477 | 45,738 | 42,574 |
| TOTAL | $92,998 | $84,654 | $82,453 | $94,746 | $101,742 |
| Total Liabilities | $146,818 | $136,414 | $119,734 | $151,715 | $153,474 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,491 | 6,330 | 6,250 | 5,870 | 5,501 |
| Common Shares | 97 | 95 | 112 | 899 | 740 |
| Retained earnings | -491,582 | -482,760 | -477,465 | -461,918 | -448,604 |
| Other shareholders' equity | 138,323 | 96,661 | 79,034 | 56,381 | 37,987 |
| TOTAL | $244,225 | $196,999 | $176,145 | $116,858 | $75,285 |
| Total Liabilities And Equity | $391,043 | $333,413 | $295,879 | $268,573 | $228,759 |